Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules

Purpose To determine the outcomes after initial therapy in patients with chronic liver disease and retrospectively assigned Liver Imaging Reporting and Data System (LI-RADS; version 2014) category 4 (LR-4) and 5 (LR-5) nodules at gadoxetate disodium-enhanced MR imaging. Materials and Methods In this...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Radiology 2018-05, Vol.287 (2), p.515-524
Hauptverfasser: Choi, Sang Hyun, Byun, Jae Ho, Lim, Young-Suk, Lee, So Jung, Kim, So Yeon, Won, Hyung Jin, Shin, Yong Moon, Kim, Pyo-Nyun
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 524
container_issue 2
container_start_page 515
container_title Radiology
container_volume 287
creator Choi, Sang Hyun
Byun, Jae Ho
Lim, Young-Suk
Lee, So Jung
Kim, So Yeon
Won, Hyung Jin
Shin, Yong Moon
Kim, Pyo-Nyun
description Purpose To determine the outcomes after initial therapy in patients with chronic liver disease and retrospectively assigned Liver Imaging Reporting and Data System (LI-RADS; version 2014) category 4 (LR-4) and 5 (LR-5) nodules at gadoxetate disodium-enhanced MR imaging. Materials and Methods In this retrospective study, 260 patients with a single LR-4 (n = 132) or LR-5 (n = 128) nodule who were assigned a LI-RADS category were included. Patients were identified between January 2012 and December 2012, and were initially treated by resection, liver transplant, radiofrequency ablation (RFA), or transcatheter arterial chemoembolization (TACE) according to the Barcelona Clinic Liver Cancer staging system. Follow-up continued until August 31, 2016. The incidences of local tumor recurrence (ILRs) and distant tumor recurrence (IDRs) and recurrence-free survival (RFS) were compared between the LR-4 and LR-5 patients. For each category, ILRs, IDRs, and RFS were compared across the four treatments. Results LR-5 patients were more frequently treated by surgical resection than LR-4 patients (72.7% [93 of 128] vs 41.7% [55 of 132], respectively; P < .001), but less frequently treated by RFA (19.5% [25 of 128] vs 30.3% [40 of 132], respectively; P = .047) and TACE (6.3% [eight of 128] vs 22.0% [29 of 132], respectively; P < .001). ILRs and IDRs were not significantly different between LR-4 and LR-5 patients according to the type of treatment (0%-48.3% [14 of 29] vs 0%-25.0% [two of eight], P $ .423; 0%-55.2% [16 of 29] vs 0%-37.5% [three of eight], P $ .447, respectively). There was no difference in RFS between the two categories (36.3 months vs 41.7 months, respectively; P = .084). Liver transplant showed no local or distant tumor recurrence in either category. Resection showed higher RFS and lower ILR and IDR than RFA and TACE in both LR-4 and LR-5 patients. Conclusion Patients with LR-4 nodules had ILRs and IDRs similar to patients with LR-5 nodules when stratified by treatment type. RFS was also similar between patients with LR-4 and LR-5 nodules. Among the four initial treatments, liver transplant and resection showed better local tumor control, with longer RFS than RFA or TACE. RSNA, 2018 Online supplemental material is available for this article.
doi_str_mv 10.1148/radiol.2018170748
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2007115111</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007115111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-d7043dc82f3c80dbf5bb9b16f4a5097f03f9e90699a77ed77dc7acfd1a2f81cb3</originalsourceid><addsrcrecordid>eNpFkElPwzAYRC0EoqXwA7ggH7mk-Iud2uaGylapoojtGjleqqAkLraD1H9PS1lOM4d5c3gInQIZAzBxEZSpfTPOCQjghDOxh4ZQ5DwDCsU-GhJCaSYYyAE6ivGdEGCF4IdokEtWcDlhQ_Q2rz9twLNWLetuiZ_syoe0baoz-FolhZ_XMdn2Ej-qVNsu4UWftG9txM4HPFXJLn1YY_YNFPjBm76x8RgdONVEe_KTI_R6e_Myvc_mi7vZ9GqeacpYygwnjBotcke1IKZyRVXJCiaOqYJI7gh10koykVJxbg3nRnOlnQGVOwG6oiN0vvtdBf_R25jKto7aNo3qrO9jmRPCAQoA2ExhN9XBxxisK1ehblVYl0DKrc5yp7P817lhzn7u-6q15o_49Ue_ABgqcbc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007115111</pqid></control><display><type>article</type><title>Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Choi, Sang Hyun ; Byun, Jae Ho ; Lim, Young-Suk ; Lee, So Jung ; Kim, So Yeon ; Won, Hyung Jin ; Shin, Yong Moon ; Kim, Pyo-Nyun</creator><creatorcontrib>Choi, Sang Hyun ; Byun, Jae Ho ; Lim, Young-Suk ; Lee, So Jung ; Kim, So Yeon ; Won, Hyung Jin ; Shin, Yong Moon ; Kim, Pyo-Nyun</creatorcontrib><description>Purpose To determine the outcomes after initial therapy in patients with chronic liver disease and retrospectively assigned Liver Imaging Reporting and Data System (LI-RADS; version 2014) category 4 (LR-4) and 5 (LR-5) nodules at gadoxetate disodium-enhanced MR imaging. Materials and Methods In this retrospective study, 260 patients with a single LR-4 (n = 132) or LR-5 (n = 128) nodule who were assigned a LI-RADS category were included. Patients were identified between January 2012 and December 2012, and were initially treated by resection, liver transplant, radiofrequency ablation (RFA), or transcatheter arterial chemoembolization (TACE) according to the Barcelona Clinic Liver Cancer staging system. Follow-up continued until August 31, 2016. The incidences of local tumor recurrence (ILRs) and distant tumor recurrence (IDRs) and recurrence-free survival (RFS) were compared between the LR-4 and LR-5 patients. For each category, ILRs, IDRs, and RFS were compared across the four treatments. Results LR-5 patients were more frequently treated by surgical resection than LR-4 patients (72.7% [93 of 128] vs 41.7% [55 of 132], respectively; P &lt; .001), but less frequently treated by RFA (19.5% [25 of 128] vs 30.3% [40 of 132], respectively; P = .047) and TACE (6.3% [eight of 128] vs 22.0% [29 of 132], respectively; P &lt; .001). ILRs and IDRs were not significantly different between LR-4 and LR-5 patients according to the type of treatment (0%-48.3% [14 of 29] vs 0%-25.0% [two of eight], P $ .423; 0%-55.2% [16 of 29] vs 0%-37.5% [three of eight], P $ .447, respectively). There was no difference in RFS between the two categories (36.3 months vs 41.7 months, respectively; P = .084). Liver transplant showed no local or distant tumor recurrence in either category. Resection showed higher RFS and lower ILR and IDR than RFA and TACE in both LR-4 and LR-5 patients. Conclusion Patients with LR-4 nodules had ILRs and IDRs similar to patients with LR-5 nodules when stratified by treatment type. RFS was also similar between patients with LR-4 and LR-5 nodules. Among the four initial treatments, liver transplant and resection showed better local tumor control, with longer RFS than RFA or TACE. RSNA, 2018 Online supplemental material is available for this article.</description><identifier>ISSN: 0033-8419</identifier><identifier>EISSN: 1527-1315</identifier><identifier>DOI: 10.1148/radiol.2018170748</identifier><identifier>PMID: 29457964</identifier><language>eng</language><publisher>United States</publisher><ispartof>Radiology, 2018-05, Vol.287 (2), p.515-524</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-d7043dc82f3c80dbf5bb9b16f4a5097f03f9e90699a77ed77dc7acfd1a2f81cb3</citedby><cites>FETCH-LOGICAL-c344t-d7043dc82f3c80dbf5bb9b16f4a5097f03f9e90699a77ed77dc7acfd1a2f81cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29457964$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choi, Sang Hyun</creatorcontrib><creatorcontrib>Byun, Jae Ho</creatorcontrib><creatorcontrib>Lim, Young-Suk</creatorcontrib><creatorcontrib>Lee, So Jung</creatorcontrib><creatorcontrib>Kim, So Yeon</creatorcontrib><creatorcontrib>Won, Hyung Jin</creatorcontrib><creatorcontrib>Shin, Yong Moon</creatorcontrib><creatorcontrib>Kim, Pyo-Nyun</creatorcontrib><title>Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules</title><title>Radiology</title><addtitle>Radiology</addtitle><description>Purpose To determine the outcomes after initial therapy in patients with chronic liver disease and retrospectively assigned Liver Imaging Reporting and Data System (LI-RADS; version 2014) category 4 (LR-4) and 5 (LR-5) nodules at gadoxetate disodium-enhanced MR imaging. Materials and Methods In this retrospective study, 260 patients with a single LR-4 (n = 132) or LR-5 (n = 128) nodule who were assigned a LI-RADS category were included. Patients were identified between January 2012 and December 2012, and were initially treated by resection, liver transplant, radiofrequency ablation (RFA), or transcatheter arterial chemoembolization (TACE) according to the Barcelona Clinic Liver Cancer staging system. Follow-up continued until August 31, 2016. The incidences of local tumor recurrence (ILRs) and distant tumor recurrence (IDRs) and recurrence-free survival (RFS) were compared between the LR-4 and LR-5 patients. For each category, ILRs, IDRs, and RFS were compared across the four treatments. Results LR-5 patients were more frequently treated by surgical resection than LR-4 patients (72.7% [93 of 128] vs 41.7% [55 of 132], respectively; P &lt; .001), but less frequently treated by RFA (19.5% [25 of 128] vs 30.3% [40 of 132], respectively; P = .047) and TACE (6.3% [eight of 128] vs 22.0% [29 of 132], respectively; P &lt; .001). ILRs and IDRs were not significantly different between LR-4 and LR-5 patients according to the type of treatment (0%-48.3% [14 of 29] vs 0%-25.0% [two of eight], P $ .423; 0%-55.2% [16 of 29] vs 0%-37.5% [three of eight], P $ .447, respectively). There was no difference in RFS between the two categories (36.3 months vs 41.7 months, respectively; P = .084). Liver transplant showed no local or distant tumor recurrence in either category. Resection showed higher RFS and lower ILR and IDR than RFA and TACE in both LR-4 and LR-5 patients. Conclusion Patients with LR-4 nodules had ILRs and IDRs similar to patients with LR-5 nodules when stratified by treatment type. RFS was also similar between patients with LR-4 and LR-5 nodules. Among the four initial treatments, liver transplant and resection showed better local tumor control, with longer RFS than RFA or TACE. RSNA, 2018 Online supplemental material is available for this article.</description><issn>0033-8419</issn><issn>1527-1315</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpFkElPwzAYRC0EoqXwA7ggH7mk-Iud2uaGylapoojtGjleqqAkLraD1H9PS1lOM4d5c3gInQIZAzBxEZSpfTPOCQjghDOxh4ZQ5DwDCsU-GhJCaSYYyAE6ivGdEGCF4IdokEtWcDlhQ_Q2rz9twLNWLetuiZ_syoe0baoz-FolhZ_XMdn2Ej-qVNsu4UWftG9txM4HPFXJLn1YY_YNFPjBm76x8RgdONVEe_KTI_R6e_Myvc_mi7vZ9GqeacpYygwnjBotcke1IKZyRVXJCiaOqYJI7gh10koykVJxbg3nRnOlnQGVOwG6oiN0vvtdBf_R25jKto7aNo3qrO9jmRPCAQoA2ExhN9XBxxisK1ehblVYl0DKrc5yp7P817lhzn7u-6q15o_49Ue_ABgqcbc</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Choi, Sang Hyun</creator><creator>Byun, Jae Ho</creator><creator>Lim, Young-Suk</creator><creator>Lee, So Jung</creator><creator>Kim, So Yeon</creator><creator>Won, Hyung Jin</creator><creator>Shin, Yong Moon</creator><creator>Kim, Pyo-Nyun</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201805</creationdate><title>Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules</title><author>Choi, Sang Hyun ; Byun, Jae Ho ; Lim, Young-Suk ; Lee, So Jung ; Kim, So Yeon ; Won, Hyung Jin ; Shin, Yong Moon ; Kim, Pyo-Nyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-d7043dc82f3c80dbf5bb9b16f4a5097f03f9e90699a77ed77dc7acfd1a2f81cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choi, Sang Hyun</creatorcontrib><creatorcontrib>Byun, Jae Ho</creatorcontrib><creatorcontrib>Lim, Young-Suk</creatorcontrib><creatorcontrib>Lee, So Jung</creatorcontrib><creatorcontrib>Kim, So Yeon</creatorcontrib><creatorcontrib>Won, Hyung Jin</creatorcontrib><creatorcontrib>Shin, Yong Moon</creatorcontrib><creatorcontrib>Kim, Pyo-Nyun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choi, Sang Hyun</au><au>Byun, Jae Ho</au><au>Lim, Young-Suk</au><au>Lee, So Jung</au><au>Kim, So Yeon</au><au>Won, Hyung Jin</au><au>Shin, Yong Moon</au><au>Kim, Pyo-Nyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules</atitle><jtitle>Radiology</jtitle><addtitle>Radiology</addtitle><date>2018-05</date><risdate>2018</risdate><volume>287</volume><issue>2</issue><spage>515</spage><epage>524</epage><pages>515-524</pages><issn>0033-8419</issn><eissn>1527-1315</eissn><abstract>Purpose To determine the outcomes after initial therapy in patients with chronic liver disease and retrospectively assigned Liver Imaging Reporting and Data System (LI-RADS; version 2014) category 4 (LR-4) and 5 (LR-5) nodules at gadoxetate disodium-enhanced MR imaging. Materials and Methods In this retrospective study, 260 patients with a single LR-4 (n = 132) or LR-5 (n = 128) nodule who were assigned a LI-RADS category were included. Patients were identified between January 2012 and December 2012, and were initially treated by resection, liver transplant, radiofrequency ablation (RFA), or transcatheter arterial chemoembolization (TACE) according to the Barcelona Clinic Liver Cancer staging system. Follow-up continued until August 31, 2016. The incidences of local tumor recurrence (ILRs) and distant tumor recurrence (IDRs) and recurrence-free survival (RFS) were compared between the LR-4 and LR-5 patients. For each category, ILRs, IDRs, and RFS were compared across the four treatments. Results LR-5 patients were more frequently treated by surgical resection than LR-4 patients (72.7% [93 of 128] vs 41.7% [55 of 132], respectively; P &lt; .001), but less frequently treated by RFA (19.5% [25 of 128] vs 30.3% [40 of 132], respectively; P = .047) and TACE (6.3% [eight of 128] vs 22.0% [29 of 132], respectively; P &lt; .001). ILRs and IDRs were not significantly different between LR-4 and LR-5 patients according to the type of treatment (0%-48.3% [14 of 29] vs 0%-25.0% [two of eight], P $ .423; 0%-55.2% [16 of 29] vs 0%-37.5% [three of eight], P $ .447, respectively). There was no difference in RFS between the two categories (36.3 months vs 41.7 months, respectively; P = .084). Liver transplant showed no local or distant tumor recurrence in either category. Resection showed higher RFS and lower ILR and IDR than RFA and TACE in both LR-4 and LR-5 patients. Conclusion Patients with LR-4 nodules had ILRs and IDRs similar to patients with LR-5 nodules when stratified by treatment type. RFS was also similar between patients with LR-4 and LR-5 nodules. Among the four initial treatments, liver transplant and resection showed better local tumor control, with longer RFS than RFA or TACE. RSNA, 2018 Online supplemental material is available for this article.</abstract><cop>United States</cop><pmid>29457964</pmid><doi>10.1148/radiol.2018170748</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-8419
ispartof Radiology, 2018-05, Vol.287 (2), p.515-524
issn 0033-8419
1527-1315
language eng
recordid cdi_proquest_miscellaneous_2007115111
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A58%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20Imaging%20Reporting%20and%20Data%20System:%20Patient%20Outcomes%20for%20Category%204%20and%205%20Nodules&rft.jtitle=Radiology&rft.au=Choi,%20Sang%20Hyun&rft.date=2018-05&rft.volume=287&rft.issue=2&rft.spage=515&rft.epage=524&rft.pages=515-524&rft.issn=0033-8419&rft.eissn=1527-1315&rft_id=info:doi/10.1148/radiol.2018170748&rft_dat=%3Cproquest_cross%3E2007115111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007115111&rft_id=info:pmid/29457964&rfr_iscdi=true